Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality-Reference-Cited by-同舟云学术

Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality

Published:2019-11 Issue:11 Volume:7 Page:970-979
ISSN:2213-1779
Container-title:JACC: Heart Failure
language:en
Short-container-title:JACC: Heart Failure

Author:

Beusekamp Joost C.,Tromp Jasper,Cleland John G.F.,Givertz Michael M.,Metra Marco,O’Connor Christopher M.,Teerlink John R.,Ponikowski Piotr,Ouwerkerk Wouter,van Veldhuisen Dirk J.,Voors Adriaan A.,van der Meer Peter

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference32 articles.

1. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system;Palmer;N Engl J Med,2004

2. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study;Juurlink;N Engl J Med,2004

3. Evaluation of the treatment gap between clinical guidelines and the utilization of renin-angiotensin-aldosterone system inhibitors;Epstein;Am J Manag Care,2015

4. Long-term potassium monitoring and dynamics in heart failure and risk of mortality;Núñez;Circulation,2018

5. Associations of serum potassium levels with mortality in chronic heart failure patients;Aldahl;Eur Heart J,2017

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium-glucose cotransporter-2 inhibitors and abnormal serum potassium: a real-world, pharmacovigilance study;Journal of Cardiovascular Medicine;2024-06-27

2. Economic impact of the use of patiromer in chronic kidney disease or heart failure for the treatment of chronic hyperkalemia in Spain;Nefrología (English Edition);2023-11

3. Potassium homeostasis – Physiology and pharmacology in a clinical context;Pharmacology & Therapeutics;2023-09

4. Impact of ACEIs and ARBs-related adverse drug reaction on patients’ clinical outcomes: a cohort study in UK primary care;British Journal of General Practice;2023-07-04

5. A Real-World Analysis of Post-Marketing Surveillance Data Assessing the Incidence of Hyperkalemia or Acute Kidney Injury in Patients on Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin-Receptor Blockers;Reviews in Cardiovascular Medicine;2023-04-13